Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-17-033985

Options or other derivatives

  • Director acquired 19,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
FORMELA JEAN FRANCOIS Director 2017-05-18 Grant or award · Stock Option (right to buy) +19,000 19,000 D
Loading xslF345X03/doc4.xml…